Anthony Cheung
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anthony Cheung
Anthony Cheung is recorded as CTO at enGene Therapeutics Inc. (ENGN). enGene Therapeutics Inc. reported in an 8-K filed October 21, 2024 that Anthony Cheung was appointed Chief Scientific Officer, effective October 21, 2024.
“Effective October 21, 2024, Dr. Anthony Cheung’s title and role changed from Chief Technology Officer to Chief Scientific Officer, succeeding Dr. James Sullivan as Chief Scientific Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-11-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at enGene Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Joan Connolly CTO
- Dr. William Grossman Board Member
- Gerald Brunk Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.